Saab 9-3 Se Convertible on 2040-cars

Auto blog

Dealership refunds student for broken Saab with bags of pennies

Every so often, we come across the story of someone trying to "stick it to the man" by paying a parking fine or speeding ticket in pennies or dimes. Never, though, have we heard of a business stooping to such cliched lengths. Enter Florida. Irena Mujakovic bought a 2003 Saab way back in January from Holiday Motors, in Jacksonville, FL. Shortly after the purchase, the transmission started acting up. She returned to the dealer and paid for the repair, and purchased a warranty for future issues. Total cost: $300. But then the trans crapped out not long after the initial repair, and Mujakovic was back at Holiday Motors. This is where things start going south. This second trip cost Mujakovic $400, with her warranty in hand. That's because the man that runs the dealer, Ed Di Miranda, neglected to mention that the warranty didn't cover labor costs. "The warranty did not cover labor and I failed to write that in and that was her loophole," Di Miranda told First Coast News. The young college student filed a complaint with the Florida DMV, who sided with her and ordered Holiday Motors to refund the money. Di Miranda and the dealership did just that, but when Mujakovic came to collect her refund, it was to a bag of pennies, with a few dollar bills sprinkled in for good measure. Di Miranda, doesn't seem to think he's done anything wrong, claiming that only about $85 was in change, while the rest was paper money. "I am doing what DMV asked me to do," Di Miranda said. "It is legal tender." Mujakovic has not collected her refund. Have a look below for the video news report. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. News Source: First Coast News via Jalopnik Car Buying Government/Legal Car Buying Saab

Spyker files $3 billion lawsuit against General Motors over Saab's demise

"Smack." That's the sound of Spyker's process server dropping a big ol' pile of legal documents on the doorstep of The Renaissance Center, home of General Motors - or wherever GM's attorneys live during business hours. Contained therein is a Complaint, filed in the U.S. District Court for the Eastern District of Michigan and demanding a jury trial, that seeks $3 billion in damages due to "the unlawful actions GM took to avoid competition with Saab Automobile in the Chinese market." Spyker accuses GM of "tortiously interfering" with Saab's business relationship with Chinese automaker Zhejiang Youngman Lotus Automobile (Youngman), actions that Spyker CEO Victor Muller (above) said "deliberately drove Saab Automobile into bankruptcy."
(From Wikipedia: "Tortious interference, also known as intentional interference with contractual relations, in the common law of torts, occurs when a person intentionally damages the plaintiff's contractual or other business relationships.")
The interference in question specifically refers to the very last potential deal, called the Framework Agreement, that Spyker worked out with Youngman. With lots of GM engineering embedded into the 9-4X and 9-5, The General had the right to approve any Saab partnership that would involve the transfer of GM intellectual property. Spyker had been rebuffed over every previous deal with a Chinese firm, including two bids by Youngman, due to GM concerns over its IP getting into Chinese hands and having to face Chinese-market competitors using its technology. The Complaint alleges that the Framework Agreement would have put a firewall around all GM IP - Youngman would only work on Saab's Phoenix platform, said to be just about free of GM tech, and would have no access to 9-3, 9-4X or 9-5 technology until after Saab ceased all ties to GM.

NEVS, the company that took over Saab, gets new majority owner

Chinese real estate conglomerate Evergrande Group, a key investor behind troubled electric vehicle startup Faraday Future, has acquired a 51 percent stake in NEVS. That's the Chinese-backed Swedish electric vehicle company that purchased the assets of Saab out of bankruptcy in 2012. The investment by subsidiary Evergrande Health Industry Group was valued at the equivalent of $930 million and is expected to help NEVS develop new EVs. Evergrande said it paid the first installment of $430 million on Jan. 15, with the remainder due by the end of the month. The remaining 49 percent stake is controlled by a holding company controlled by NEVS founder Kai Johan Jiang. "It means that NEVS will get a financial (sic) strong main owner who is very interested in developing our vision about green mobility transport solutions for the future," NEVS CEO Stefan Tilk said in a statement. NEVS, short for National Electric Vehicle Sweden, owns production facilities in Trollhattan, Sweden, and Tianjin, China, with another under construction in Shanghai. In late 2017 the company launched what apparently was limited production of the 9-3 EV, an electric vehicle based — you guessed it — on the old Saab 9-3 platform. The company now says it will be built in Tianjin starting later this year, with components coming from Trollhattan. It boasts a 186-mile range, in-car WiFi and a cabin air filter for the notoriously smoggy Chinese air. It also showed a battery-electric 9-3X concept at CES Asia in 2017, which is likely to be its next model pegged for production. The South China Morning Post, citing local media reports, says two of NEVS' models meet the standards for mass production in China. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. Definitely the best promotional video we've ever seen. Evergrande Health first came to Faraday Future's rescue back in 2017 with a promised $2 billion investment, but the two sides later went into arbitration in Hong Kong over a dispute about money following the first infusion of $800 million, leading the automaker to cut staff and wages last year, casting the future of FF into doubt. At the end of 2018, Faraday announced it had entered into a new restructuring agreement with an Evergrande Health subsidiary that sees them end litigation and jettison the previous investment agreement, taking Evergrande's investment in the company to 32 percent.